These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 7498360

  • 1. Circulating CFU-E during hematopoietic recovery after allogeneic bone marrow transplantation: relationship to erythroid engraftment.
    Vannucchi AM, Bosi A, Lombardini L, Grossi A, Bacci P, Guidi S, Saccardi R, Rossi-Ferrini P.
    Exp Hematol; 1995 Dec; 23(13):1337-40. PubMed ID: 7498360
    [Abstract] [Full Text] [Related]

  • 2. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM, Fortuna A, Fogli M, Gherlinzoni F, Rosti G, Catani L, Gozzetti A, Miggiano MC, Tura S.
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [Abstract] [Full Text] [Related]

  • 3. High doses of recombinant human erythropoietin fail to accelerate platelet reconstitution in allogeneic bone marrow transplantation. Results of a pilot study.
    Vannucchi AM, Bosi A, Linari S, Guidi S, Longo G, Lombardini L, Mariani MP, Saccardi R, Laszlo D, Rossi Ferrini P.
    Haematologica; 1997 Dec; 82(1):53-6. PubMed ID: 9107083
    [Abstract] [Full Text] [Related]

  • 4. In vitro sensitivity of post-bone marrow transplantation CFU-GM and BFU-E to TNF-alpha and IFN-gamma.
    Papadakis V, Ferguson KF, Heller G, Kernan NA.
    Exp Hematol; 1995 Dec; 23(14):1422-30. PubMed ID: 8542927
    [Abstract] [Full Text] [Related]

  • 5. Effects of in vivo treatment with PIXY321 (GM-CSF/IL-3 fusion protein) on proliferation kinetics of bone marrow and blood myeloid progenitor cells in patients with sarcoma.
    Broxmeyer HE, Benninger L, Cooper S, Hague N, Benjamin RS, Vadhan-Raj S.
    Exp Hematol; 1995 Apr; 23(4):335-40. PubMed ID: 7895781
    [Abstract] [Full Text] [Related]

  • 6. Optimal erythroid cell production during erythropoietin treatment of mice occurs by exploiting the splenic microenvironment.
    Nijhof W, Goris H, Dontje B, Dresz J, Loeffler M.
    Exp Hematol; 1993 Apr; 21(4):496-501. PubMed ID: 8462658
    [Abstract] [Full Text] [Related]

  • 7. Influence in vitro of IL-3/Epo fusion proteins compared with the combination of IL-3 plus Epo in enhancing the proliferation of single isolated erythroid and multipotential progenitor cells from human umbilical cord blood and adult bone marrow.
    Lu L, Xiao M, Li ZH, Jolliffe LK, Jones S, Broxmeyer HE, Weich N.
    Exp Hematol; 1995 Sep; 23(10):1130-4. PubMed ID: 7656932
    [Abstract] [Full Text] [Related]

  • 8. Combination therapy with G-CSF and erythropoietin after autologous bone marrow transplantation for lymphoid malignancies: a randomized trial.
    Vannucchi AM, Bosi A, Ieri A, Guidi S, Saccardi R, Lombardini L, Linari S, Laszlo D, Longo G, Rossi-Ferrini P.
    Bone Marrow Transplant; 1996 Apr; 17(4):527-31. PubMed ID: 8722349
    [Abstract] [Full Text] [Related]

  • 9. Physician Education: The Erythropoietin Receptor and Signal Transduction.
    Yoshimura A, Arai K.
    Oncologist; 1996 Apr; 1(5):337-339. PubMed ID: 10388012
    [Abstract] [Full Text] [Related]

  • 10. Studies of W mutant mice provide evidence for alternate mechanisms capable of activating hematopoietic stem cells.
    Miller CL, Rebel VI, Lemieux ME, Helgason CD, Lansdorp PM, Eaves CJ.
    Exp Hematol; 1996 Feb; 24(2):185-94. PubMed ID: 8641340
    [Abstract] [Full Text] [Related]

  • 11. Dynamics of erythropoietic recovery following bone marrow transplantation: role of marrow proliferative capacity and erythropoietin production in autologous versus allogeneic transplants.
    Beguin Y, Oris R, Fillet G.
    Bone Marrow Transplant; 1993 Apr; 11(4):285-92. PubMed ID: 8485476
    [Abstract] [Full Text] [Related]

  • 12. Hematopoietic progenitor cells from allogeneic bone marrow transplant donors circulate in the very early post-transplant period.
    Katayama Y, Mahmut N, Takimoto H, Maeda Y, Yano T, Kojima K, Azuma T, Hara M, Imajyo K, Takahashi S, Kai T, Ohno Y, Miyamoto T, Nagafuji K, Matsue K, Takenaka K, Teshima T, Shinagawa K, Ishimaru F, Omoto E, Harada M.
    Bone Marrow Transplant; 1999 Apr; 23(7):659-65. PubMed ID: 10218841
    [Abstract] [Full Text] [Related]

  • 13. Stimulation of erythroid engraftment by recombinant human erythropoietin in ABO-compatible, HLA-identical, allogeneic bone marrow transplant patients.
    Vannucchi AM, Bosi A, Grossi A, Guidi S, Saccardi R, Lombardini L, Rossi-Ferrini P.
    Leukemia; 1992 Mar; 6(3):215-9. PubMed ID: 1564959
    [Abstract] [Full Text] [Related]

  • 14. Comparison between bone marrow and G-CSF-mobilized peripheral blood allografts undergoing clinical scale CD34+ cell selection.
    Hassan HT, Zeller W, Stockschläder M, Krüger W, Hoffknecht MM, Zander AR.
    Stem Cells; 1996 Jul; 14(4):419-29. PubMed ID: 8843543
    [Abstract] [Full Text] [Related]

  • 15. Special Education.
    Kozutsumi H.
    Oncologist; 1996 Jul; 1(1 & 2):116-118. PubMed ID: 10387976
    [Abstract] [Full Text] [Related]

  • 16. The effect of recombinant human erythropoietin on circulating hematopoietic progenitor cells in anemic premature infants.
    Meister B, Maurer H, Simma B, Kern H, Ulmer H, Hittmair A, Fink FM.
    Stem Cells; 1997 Jul; 15(5):359-63. PubMed ID: 9323798
    [Abstract] [Full Text] [Related]

  • 17. In vitro busulfan sensitivity of granulocyte-macrophage and erythroid progenitor cells in patients with chronic myelogenous leukemia.
    Kubota K, Preisler HD, Costanzo C, Miura Y.
    Cancer Res; 1983 Dec; 43(12 Pt 1):6090-3. PubMed ID: 6580066
    [Abstract] [Full Text] [Related]

  • 18. Recovery of circulating haemopoietic progenitor cells in the early phase of haemopoietic reconstitution after autologous and allogeneic bone marrow transplantation.
    Kwong YL, Millar JL, Powles RL.
    Bone Marrow Transplant; 1989 Sep; 4(5):575-8. PubMed ID: 2790335
    [Abstract] [Full Text] [Related]

  • 19. Peripheral blood progenitor cell mobilisation alters myeloid, but not erythroid, progenitor cell self-renewal kinetics.
    Marley SB, Lewis JL, Zheng B, Davidson RJ, Davis JG, McDonald C, Alenzi FQ, Goldman JM, Gordon MY.
    Bone Marrow Transplant; 2001 Feb; 27(3):241-8. PubMed ID: 11277171
    [Abstract] [Full Text] [Related]

  • 20. Flow cytometric analysis of human bone marrow perfusion cultures: erythroid development and relationship with burst-forming units-erythroid.
    Rogers CE, Bradley MS, Palsson BO, Koller MR.
    Exp Hematol; 1996 Apr; 24(5):597-604. PubMed ID: 8605964
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.